Latest Breaking News On - மைனர் இனங்கள் - Page 1 : comparemela.com
Jaguar Health Receives Complete Letter from FDA for Last of Four Major Technical Sections for the Company s Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
FDA grants lymphoma cancer treatment in dogs full approval
foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.
FDA Grants First Full Approval for Treatment of Lymphoma in Dogs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
FDA Grants First Full Approval for Treatment of Lymphoma in Dogs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Anivive Awarded $500,000 Grant by the FDA for Canine Cancer Studies
- Anivive is the first recipient to be awarded a MUMS grant during this round of funding
- Funding will accelerate ongoing canine lymphoma studies
- Anivive to initiate studies of verdinexor to treat other types of cancer
News provided by
Share this article
Share this article
LONG BEACH, Calif., July 8, 2021 /PRNewswire/ Anivive, a pet health technology company transforming the therapeutic discovery and development process, received $500,000 in grant funding to continue research on the use of LAVERDIA™ -CA1 (verdinexor) in the treatment of canine lymphoma.
The grant was received from the U.S. Food and Drug Administration as part of the agency s Minor Use/Minor Species program, developed to support new animal drugs intended for uncommon or undertreated diseases such as canine lymphoma. Anivive was one of four companies selected for the grants.